PUMA BIOTECHNOLOGY, INC. (PBYI) › Cash & EquivalentsPUMA BIOTECHNOLOGY, INC. (PBYI) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $02011: $53.38M2012: $137.41M2013: $43.04M2014: $38.54M2015: $31.57M2016: $194.49M2017: $81.70M2018: $108.42M2019: $60.04M2020: $85.29M2021: $63.13M2022: $76.20M2023: $84.58M2024: $69.22M2025: $29.64M$29.64M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$29.64M-57.2%2024$69.22M-18.2%2023$84.58M+11.0%2022$76.20M+20.7%2021$63.13M-26.0%2020$85.29M+42.1%2019$60.04M-44.6%2018$108.42M+32.7%2017$81.70M-58.0%2016$194.49M+516.1%2015$31.57M-18.1%2014$38.54M-10.5%2013$43.04M-68.7%2012$137.41M+157.4%2011$53.38M—2010$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share